Search Results 391-400 of 6055 for albumin

1. A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia - Mayo Clinic

   About this study. The purpose of this study is to collect blood and stool samples to validate and improve the performance of stool and blood DNA markers for ...

2. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

3. Detection and Identification of Bacterial and Fungal DNA in Blood - Mayo Clinic

   This study includes collection of blood samples from the healthy controls and those with suspected bloodstream infections. Participation eligibility.

4. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

   - Albumin >= 3.0 g/dL - Prothrombin time (PT)/activated partial thromboplastin time (aPTT) =< 1.5 x ULN (This applies only to patients who do not receive ...

5. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

   ... albumin-bound paclitaxel, or docetaxel. Histologic confirmation of the primary tumor is required. Eligible histologies include serous, endometrioid, clear ...

6. A Study of Deep Phenotyping in Patients With ALS - Mayo Clinic

   The purpose of this study is to establish a biorepository and phenotyping database to investigate longitudinal changes in ALS subjects. Blood, including DNA and ...

7. A Study of Whole Blood-based Blood Biomarker (i.e., cytokine) that May Predict Status and Severity of Diseases - Mayo Clinic

   The purpose of this study is to see if whole blood-based blood biomarker (i.e., cytokine) predicts status and severity of diseases such as asthma, Juvenile ...

8. Publications - Matthew M. Melin, M.D. - Mayo Clinic

   Epub 2022 Mar 29. View PubMed; Zwart SR, Aunon-Chancellor SM, Heer M, Melin MM, Smith SM. Albumin, oral contraceptives, and venous thromboembolism risk in ...

9. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic ...

10. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    Albumin > 2.5 g/dL; Females of childbearing potential must have a negative serum pregnancy test within 72 hours prior to registration. NOTE: If the urine ...